BIOMAT Database Logo BIOMAT Database Logo

Identification of a RING protein that can interact in vivo with the BRCA1 gene product. 1996

L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235, USA.

The hereditary breast and ovarian cancer gene, BRCA1, encodes a large polypeptide that contains the cysteine-rich RING motif, a zinc-binding domain found in a variety of regulatory proteins. Here we describe a novel protein that interacts in vivo with the N-terminal region of BRCA1. This BRCA1-associated RING domain (BARD1) protein contains an N-terminal RING motif, three tandem ankyrin repeats, and a C-terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1. The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005260 Female Females
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell

Related Publications

L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product.
February 1991, Cell,
L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Identification of a new cellular protein that can interact specifically with DAN.
August 1997, DNA and cell biology,
L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Identification of a Ribose-Phosphate Pyrophosphokinase that Can Interact In Vivo with the Anaphase Promoting Complex/Cyclosome.
March 2017, International journal of molecular sciences,
L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Identification of proteins that interact with BRCA1 by Far-Western library screening.
January 2001, Journal of cellular biochemistry,
L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Identification of the ORC Complex Subunits That Can Interact with the ENY2 Protein of Drosophila melanogaster.
May 2018, Doklady. Biochemistry and biophysics,
L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Identification of BRCA1-IRIS, a BRCA1 locus product.
October 2004, Nature cell biology,
L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Identification of herpes simplex virus RNAs that interact specifically with regulatory protein ICP27 in vivo.
August 2003, The Journal of biological chemistry,
L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
August 1994, Oncogene,
L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Identification of genes that interact with the sina gene in Drosophila eye development.
November 1994, Proceedings of the National Academy of Sciences of the United States of America,
L C Wu, and Z W Wang, and J T Tsan, and M A Spillman, and A Phung, and X L Xu, and M C Yang, and L Y Hwang, and A M Bowcock, and R Baer
Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation.
January 2003, Journal of virology,
Copied contents to your clipboard!